November is coming to an end but
Nairo Quintana's future is soon to be determined. After testing positive for tramadol during the Tour de France, the Colombian's expected renewal with Arkéa Samsic was broken, but a solution appears to have been found.
Although he was not suspended, the bad timing in the suspension and case resolution - in which his defense failed - saw him in a very difficult position where there were few teams interested on signing a rider just off the case, and additionally many did not have the budget or space to further bring in the climber. These included the likes of Cofidis, AG2R Citroën Team and more recently Bahrain - Victorious who publicly denied interest.